Literature DB >> 33578314

Associations of exposure to perfluoroalkyl substances individually and in mixtures with persistent infections: Recent findings from NHANES 1999-2016.

Catherine M Bulka1, Vennela Avula2, Rebecca C Fry3.   

Abstract

Certain viruses and parasites can cause persistent infections that often co-occur and have been associated with substantial morbidity and mortality. Separate lines of research indicate exposures to per- and polyfluoroalkyl substances (PFAS) suppress the immune system. We hypothesized that PFAS exposures might systematically increase susceptibility to persistent infections resulting in a higher pathogen burden. We used data from 8778 individuals (3189 adolescents, 5589 adults) in the nationally-representative U.S. National Health and Nutrition Examination Survey (NHANES) 1999-2016 to examine cross-sectional associations between serum concentrations of four highly detected PFAS (PFOS, PFOA, PFHxS, PFNA) with the presence of antibodies to cytomegalovirus, Epstein Barr virus, hepatitis C and E, herpes simplex 1 and 2, HIV, T. gondii, and Toxocara spp. Seropositivity was summed to calculate a pathogen burden score reflecting the total number of infections. Separate survey-weighted multivariable regression models were fitted to analyze PFAS individually and quantile g-computation was used to analyze PFAS mixtures. Among adolescents, 38.7% had at least one persistent infection while 14.9% had two or more; among adults, these percentages were 48.0% and 19.7%. Each PFAS was individually associated with significantly higher pathogen burdens and the most pronounced associations were observed in adolescents [e.g., among adolescents, a doubling of PFOS was associated with 30% (95% CI: 25-36%) higher pathogen burden]. Quantile g-computation revealed PFAS mixtures as a whole were also associated with higher pathogen burdens. Taken together, these results suggest PFAS exposure may increase susceptibility to and foster the clustering of persistent infections, particularly among adolescents. Since persistent infections are important contributors to long-term health, prospective data are needed to confirm these findings.
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Chemical mixtures; Infectious disease; PFAS; Pathogens

Mesh:

Substances:

Year:  2021        PMID: 33578314      PMCID: PMC7957906          DOI: 10.1016/j.envpol.2021.116619

Source DB:  PubMed          Journal:  Environ Pollut        ISSN: 0269-7491            Impact factor:   8.071


  77 in total

1.  Asymptomatic infection with hepatitis C virus.

Authors:  C A Seymour
Journal:  BMJ       Date:  1994-03-12

2.  Toxoplasmosis.

Authors:  Sandra K Halonen; Louis M Weiss
Journal:  Handb Clin Neurol       Date:  2013

3.  Influenza vaccine response in adults exposed to perfluorooctanoate and perfluorooctanesulfonate.

Authors:  Claire Looker; Michael I Luster; Antonia M Calafat; Victor J Johnson; Gary R Burleson; Florence G Burleson; Tony Fletcher
Journal:  Toxicol Sci       Date:  2013-11-27       Impact factor: 4.849

4.  Identifying Risk Factors for Levels of Per- and Polyfluoroalkyl Substances (PFAS) in the Placenta in a High-Risk Pregnancy Cohort in North Carolina.

Authors:  Jacqueline Bangma; Lauren A Eaves; Kirsi Oldenburg; Jessica L Reiner; Tracy Manuck; Rebecca C Fry
Journal:  Environ Sci Technol       Date:  2020-06-12       Impact factor: 9.028

5.  Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood.

Authors:  Berit Granum; Line S Haug; Ellen Namork; Solvor B Stølevik; Cathrine Thomsen; Ingeborg S Aaberge; Henk van Loveren; Martinus Løvik; Unni C Nygaard
Journal:  J Immunotoxicol       Date:  2013-01-25       Impact factor: 3.000

6.  Chronic exposure to perfluorinated compounds: Impact on airway hyperresponsiveness and inflammation.

Authors:  Min H Ryu; Aruni Jha; Oluwaseun O Ojo; Thomas H Mahood; Sujata Basu; Karen A Detillieux; Neda Nikoobakht; Charles S Wong; Mark Loewen; Allan B Becker; Andrew J Halayko
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-09-12       Impact factor: 5.464

7.  A further critique of the analytic strategy of adjusting for covariates to identify biologic mediation.

Authors:  Jay S Kaufman; Richard F Maclehose; Sol Kaufman
Journal:  Epidemiol Perspect Innov       Date:  2004-10-08

8.  Perfluoroalkyl substances and changes in body weight and resting metabolic rate in response to weight-loss diets: A prospective study.

Authors:  Gang Liu; Klodian Dhana; Jeremy D Furtado; Jennifer Rood; Geng Zong; Liming Liang; Lu Qi; George A Bray; Lilian DeJonge; Brent Coull; Philippe Grandjean; Qi Sun
Journal:  PLoS Med       Date:  2018-02-13       Impact factor: 11.069

9.  Dietary Habits Related to Food Packaging and Population Exposure to PFASs.

Authors:  Herbert P Susmann; Laurel A Schaider; Kathryn M Rodgers; Ruthann A Rudel
Journal:  Environ Health Perspect       Date:  2019-10-09       Impact factor: 9.031

10.  Perfluoroalkyl and polyfluoroalkyl substances and indicators of immune function in children aged 12-19 y: National Health and Nutrition Examination Survey.

Authors:  Cheryl R Stein; Kathleen J McGovern; Ashley M Pajak; Paul J Maglione; Mary S Wolff
Journal:  Pediatr Res       Date:  2015-10-22       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.